Trial intelligence / Profile preview

Tramadol versus butylscopolamine for pain relief in renal colic

NL-OMON33885Phase 4Withdrawn

Sponsor
Isala
Start
Oct 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of tramadol and hyoscine butylbromide in Renal colic, sponsored by Isala. Planned start Oct 2009; status: withdrawn.

02

Drugs

tramadolhyoscine butylbromide
03

Conditions

Renal colic

Beyond the preview

Go deeper on NL-OMON33885.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON33885.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call